Affiliations 

  • 1 TCG Life Sciences (Chembiotek), Saltlake Sector V, West Bengal, India
  • 2 School of Pharmaceutical Technology, Adamas University, Barasat, Kolkata, West Bengal, India | Dr. B.C. Roy College of Pharmacy and Allied Health Sciences, Durgapur, 713 206, West Bengal, India
  • 3 Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia | Laureate Institute of Pharmacy, Kathog, Kangra, Himachal Pradesh 177101, India
  • 4 Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia
Mini Rev Med Chem, 2021;21(19):3037-3051.
PMID: 34036911 DOI: 10.2174/1389557521666210525120325

Abstract

Effective treatment of tuberculosis has been hampered by the emergence of drug-resistant strains of Mycobacterium therapeutic facilities tuberculosis. With the global resurgence of tuberculosis with the development of multidrug-resistant cases, there is a call for the development of new drugs to combat these diseases. Throughout history, natural products have afforded a rich source of compounds that have found many applications in the fields of medicine, pharmacy and biology, and continued to play a significant role in the drug discovery and development process. This review article depicts the various potential plant extracts as well as plant derived phytoconstituents against the H37rv, the most persistent strains of Mycobacterium tuberculosis and its multidrug strains.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.